Lupus News

Approximately 35% of relevant industry payments to U.S.-based authors of American College of Rheumatology clinical practice guidelines remain undisclosed, according to findings published in Arthritis & Rheumatology.

Older adults who reported hypersomnolence were more likely to have several other medical conditions, according to findings of a longitudinal study that will be presented at the American Academy of Neurology annual meeting this spring.

SCOTTSDALE, Ariz. — Characteristic microbiome imbalances in patients with lupus could potentially act as both the cause and effect of high lupus disease activity, according to Gregg Silverman, MD, of the New York University School of Medicine.

Rituximab may be a promising option for treatment-refractory childhood-onset lupus erythematosus panniculitis, according to a retrospective, observational case series published in JAMA Dermatology.

Patients of lower socioeconomic status, determined through area-level household income, had a greater incidence of both ANCA-related glomerulonephritis and lupus nephritis, according to study results from British Columbia, Canada.

Among patients with systemic lupus erythematosus, rash, joint involvement and flares are positively linked with fine particulate matter pollution, according to a spatial-time cluster analysis published in Arthritis & Rheumatology.

MAUI, Hawaii — Evolution of the understanding of systemic lupus erythematosus has shaped guidelines for the disease through the decades, according to a presentation at the 2020 Rheumatology Winter Clinical Symposium.

Low hydroxychloroquine levels in the blood among patients with systemic lupus erythematosus are associated with reported nonadherence, according to a meta-analysis published in Arthritis Care & Research.

Among patients with systemic lupus erythematosus, those with hypertensive disorders of pregnancy are at twice the risk for cardiovascular outcomes as those without such disorders, according to data published in Arthritis Care & Research.

Patients with systemic lupus erythematosus who adhere to antimalarial treatments demonstrate a 39% lower risk for developing type 2 diabetes, compared with those who discontinued, according to findings published in Arthritis Care & Research.